1.The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Jung Hwan KIM ; Jae Chan KIM ; Seung Hwan SHIN ; Soo Ik CHANG ; Hyo Sil LEE ; Soo Il CHUNG
Experimental & Molecular Medicine 1999;31(4):203-209
Angiostatin is a potent angiogenesis inhibitor that is composed of the first four kringles of plasminogen fragment. Angiostatin with one less kringle molecule (kringle 1 to 3) was recently demonstrated to be an effective angiogenic inhibitor. To determine whether recombinant plasminogen kringle 1-3 (rPK1-3) can inhibit the corneal neovascularization induced by potent angiogenic factors; angiogenin, bFGF, or VEGF, hydron polymer discs each containing 2.0 microg of angiogenin, 500 ng of bFGF, or 500 ng of VEGF respectively were implanted into the corneal stroma of 138 rabbit eyes, and then discs each containing 10 microg, 12.5 microg, 20 microg or 30 microg of rPK1-3 were implanted randomly. Discs containing phosphate buffered saline were also implanted as a control. The angiogenesis score on number and length of newly formed vessels on the each of the rabbit's cornea were recorded daily by two observers (blinded). The treated corneas were also examined histologically. Recombinant PK1-3 treated corneas showed less neovascularization induced by all angiogenic factors (p < 0.05). and the extent of inhibition of neovascularization was proportional to the concentration of rPK1-3 (p < 0.05). Histologic examination showed leukocyte infiltration into the corneal stroma on the PBS treated eyes whereas rPK1-3 treated eyes showed only traces of leukocytes. These results of the effective rPK1-3 inhibition of corneal neovascularization induced by angiogenin, bFGF, or VEGF suggest that this angiostatin related fragment, rPK1-3, may be useful in the treatment of various neovascular diseases. Copyright 2000 Academic Press.
Angiogenesis Inhibitors/pharmacology*
;
Angiogenesis Inhibitors/genetics
;
Animal
;
Chick Embryo
;
Chorion/drug effects
;
Chorion/blood supply
;
Cornea/pathology
;
Cornea/drug effects
;
Cornea/blood supply*
;
Endothelial Growth Factors/pharmacology
;
Fibroblast Growth Factor, Basic/pharmacology
;
Kringles/genetics
;
Lymphokines/pharmacology
;
Microscopy/methods
;
Neovascularization, Pathologic/drug therapy*
;
Plasminogen/pharmacology*
;
Plasminogen/genetics*
;
Rabbits
;
Recombinant Proteins/pharmacology
;
Recombinant Proteins/genetics
;
Ribonuclease, Pancreatic/pharmacology
2.Purification and characterization of recombinant murine endostatin in E. coli.
Weon Kyoo YOU ; Seung Ho SO ; Hyosil LEE ; Sun Young PARK ; Mi Ran YOON ; Soo Ik CHANG ; Hyun Kyung KIM ; Young Ae JOE ; Yong Kil HONG ; Soo Il CHUNG
Experimental & Molecular Medicine 1999;31(4):197-202
Endostatin, a carboxyl-terminal fragment of collagen XVIII is known as an anti-angiogenic agent, that specifically inhibits the proliferation of endothelial cell and the growth of several primary tumor. We report here the purification and characterization of the recombinant murine endostatin (rmEndostatin) which was expressed in a prokaryotic expression system. This rmEndostatin has similar physiochemical properties of yeast-produced recombinant endostatin, and it also specifically inhibits the proliferation and migration of bovine capillary endothelial cells stimulated by basic fibroblast growth factor. The biological activity of rmEndostatin was also shown by its anti-angiogenic ability on the chorioallantoic membrane of chick embryo in vivo. In this article, we demonstrate the refolding and purification of rmEndostatin, expressed using E. coli system, to a biologically active and soluble form. In addition, these results confirm the activity of endostatin as a potent anti-angiogenic agent. Copyright 2000 Academic Press.
Angiogenesis Inhibitors/pharmacology*
;
Angiogenesis Inhibitors/isolation & purification
;
Angiogenesis Inhibitors/genetics*
;
Animal
;
Blotting, Western
;
Cattle
;
Cell Movement/drug effects
;
Chick Embryo
;
Chorion/pathology
;
Chorion/drug effects
;
Circular Dichroism
;
Collagen/pharmacology*
;
Collagen/isolation & purification
;
Collagen/genetics*
;
Electrophoresis, Polyacrylamide Gel
;
Endothelium, Vascular/drug effects
;
Endothelium, Vascular/cytology
;
Escherichia coli/genetics*
;
Fibroblast Growth Factor, Basic/pharmacology
;
Mice
;
Neovascularization, Physiologic/drug effects
;
Peptide Fragments/pharmacology*
;
Peptide Fragments/isolation & purification
;
Peptide Fragments/genetics*
;
Protein Folding
;
Recombinant Proteins/pharmacology
;
Recombinant Proteins/isolation & purification
;
Recombinant Proteins/genetics
;
Solubility
;
Yeasts/genetics